Professor Gordon Dougan focuses on the genetic analysis of host/pathogen interactions during infection. He has worked extensively in both academia and industry, making important contributions in the field of vaccinology, working to improve vaccine delivery to poorly resourced regions. His group exploit genomic approaches to study host-pathogen interactions and the analysis of microbial populations, and manages teams working on vaccines, humanised antibodies and scale-up systems.
Gordon has extensive teaching experience at both the undergraduate and postgraduate level. He is a consultant for industry and has founded biotechnology companies, including the single-chain antibody company VHSquared and Microbiotica.
Gordon is a Fellow of the Royal Society the Academy of Medical Sciences and is an EMBO (European Molecular Biology Organization) member. He established the Centre for Molecular Microbiology and Infection (including a raising funding for a building) at Imperial College London andheaded Pathogen Research for ten years (2004-2014) at the Wellcome Sanger Institute. He was winner of the Albert B Sabin Gold Medal for Vaccinology in 2020.
FRS, Albert B Sabin Gold Medal 2020